<DOC>
	<DOCNO>NCT01584037</DOCNO>
	<brief_summary>The primary purpose Adenovirus Vaccine Pregnancy Registry prospectively collect data concerning : 1 . Pregnant woman expose Adenovirus Type 4 Type 7 Vaccine , Live , Oral , 2 . Potential confounding factor , 3 . The outcome pregnancy . The secondary purpose Adenovirus Vaccine Pregnancy Registry evaluate frequency birth defect prospectively enrol pregnant woman . This Registry also design detect unusual pattern birth defect .</brief_summary>
	<brief_title>Adenovirus Vaccine Pregnancy Registry</brief_title>
	<detailed_description />
	<mesh_term>Adenoviridae Infections</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<criteria>For woman : U.S. Military service member , present former Confirmed exposure Adenovirus Type 4 Type 7 Vaccine , Live , Oral Received Adenovirus Type 4 Type 7 Vaccine , Live , Oral pregnant estimate date conception ( DOC ) within 6 week receive Adenovirus Type 4 Type 7 Vaccine , Live , Oral Positive Î²hCG test fetal ultrasound , Verbal and/or write informed consent obtain patient . For live born offspring : Infant bear woman meeting inclusion criterion enrol Registry , follow one year post delivery , Verbal and/or write informed consent obtain mother infant . Patients refuse provide informed consent ( verbal write ) Institutional Review Board ( IRB ) approve informed consent . Females expose Adenovirus Type 4 Type 7 Vaccine , Live , Oral within inclusion criterion period . Patients willing meet Registry study condition requirement .</criteria>
	<gender>Female</gender>
	<minimum_age>17 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>April 2014</verification_date>
	<keyword>Adenovirus</keyword>
	<keyword>Adenovirus Type 4</keyword>
	<keyword>Adenovirus Type 7</keyword>
	<keyword>Adenovirus Type 4 Type 7 Vaccine , Live , Oral</keyword>
</DOC>